• Press Releases.png

    Press Releases

OmniComm Systems® Attracts Record Turnout for its 6th Annual Innovation Forum

October 27, 2016


Dennis Constantinou
OmniComm Systems, Inc.

Download Press Release

Fort Lauderdale, FL, October 27, 2016 - OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, recognizes excellence in innovation at OmniComm’s 6th annual Innovation Forum customer summit. 

Attendance increased more than 20% year-over-year, with participation from 42 life science companies and partners.  Attendees heard from over 19 different OmniComm customer and partner speakers, each of whom achieved significant gains in clinical trial productivity, clinic automation, clinical data quality, operational efficiency and compliance using OmniComm’s suite of eClinical products. 

“Every year I am impressed with the increasing diversity of our client base,” said Kuno van der Post, SVP of business development at OmniComm.  “We had representatives from pharmaceutical, biotechnology, medical device, academic research, and contract research (CRO) organizations, including delegates from four of the top five global CROs.  This broad spectrum of clients is a testament to our continued market growth.  We are on pace for a record sales year with almost half our business coming from new clients.  The scalability and flexibility of our technology and our specialization in EDC is a significant contributor to that growth.”

Attendees also participated in product workshops prior to the start of the event.  These half-day workshops offered users free training and skills enhancement with TrialMaster® EDC and TrialOne®. 

“As the EDC specialist, we strive to be the pioneer in EDC technology, but the true pioneers are our customers.  Seeing the amazing value each and every customer has generated from our solutions is a moment of pride and fulfillment for our entire team,” said Cornelis Wit, CEO of OmniComm.  “The success of this conference is the result of the open sharing of customer experiences, successes and networking.  Maybe more importantly, the true measure of the user group success is the relationships that were developed which will extend the benefits for all of our users throughout the year and into the future.”

Excellence in Innovation Awards

OmniComm’s commitment to its customers extends to honoring organizations that share the passion for progress, creativity, collaboration, and advancement in life sciences.  The Excellence in Innovation Award recognizes life sciences organizations that have designed and implemented significant innovation using OmniComm’s technology and services, resulting in improved organizational operational efficiencies, best practices and business outcomes specifically for:

  • Quality - Improving the quality of the organization
  • Efficiency - Demonstrating improved operational efficiency in meeting organizational business objectives
  • Cost Effectiveness - Adding value to the organization while minimizing financial burden
  • Creativity- Degree of originality or creativeness

This year’s Excellence in Innovation Award recipients are Celerion, TFS and WCCT Global.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance.  OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 5,000 clinical trials. For more information, visit www.omnicomm.com.

OmniComm, TrialMaster, TrialOne and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.